T Cell Lymphoma
1 competing product in clinical development for T Cell Lymphoma.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Mogamulizumab + DA-EPOCH Protocol + CHOEP protocol | Kyowa Kirin | Phase 2 | Recruiting | 42 |
1 competing product in clinical development for T Cell Lymphoma.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Mogamulizumab + DA-EPOCH Protocol + CHOEP protocol | Kyowa Kirin | Phase 2 | Recruiting | 42 |